相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A randomized phase II trial evaluating the addition of low dose, short course sunitinib to docetaxel in advanced solid tumours
Yvonne L. E. Ang et al.
BMC CANCER (2020)
Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update
Antonio C. Wolff et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2018)
VEGF-C sustains VEGFR2 activation under bevacizumab therapy and promotes glioblastoma maintenance
Signe R. Michaelsen et al.
NEURO-ONCOLOGY (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Monitoring of tumor vascular normalization: the key points from basic research to clinical application
Wei Li et al.
CANCER MANAGEMENT AND RESEARCH (2018)
Antiangiogenic cancer treatment: The great discovery and greater complexity (Review)
Ewa Maj et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
Phase Ib/II randomized, open-label study of doxorubicin and cyclophosphamide with or without low-dose, short-course sunitinib in the pre-operative treatment of breast cancer
Andrea L. A. Wong et al.
ONCOTARGET (2016)
Early effects of low dose bevacizumab treatment assessed by magnetic resonance imaging
Jon-Vidar Gaustad et al.
BMC CANCER (2015)
Targeting Angiogenesis in Cancer Therapy: Moving Beyond Vascular Endothelial Growth Factor
Yujie Zhao et al.
ONCOLOGIST (2015)
Inhibiting Angiogenesis in Breast Cancer: The Beginning of the End or the End of the Beginning?
Hope S. Rugo
JOURNAL OF CLINICAL ONCOLOGY (2012)
Bevacizumab Added to Neoadjuvant Chemotherapy for Breast Cancer
Harry D. Bear et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Autocrine functions of VEGF in breast tumor cells Adhesion, survival, migration and invasion
Martine Perrot-Applanat et al.
CELL ADHESION & MIGRATION (2012)
Tumor Angiogenesis: Pericytes and Maturation Are Not to Be Ignored
Elham Fakhrejahani et al.
JOURNAL OF ONCOLOGY (2012)
RIBBON-1: Randomized, Double-Blind, Placebo-Controlled, Phase III Trial of Chemotherapy With or Without Bevacizumab for First-Line Treatment of Human Epidermal Growth Factor Receptor 2-Negative, Locally Recurrent or Metastatic Breast Cancer
Nicholas J. Robert et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
New Insights into Molecular Mechanisms of Sunitinib-Associated Side Effects
Guadalupe Aparicio-Gallego et al.
MOLECULAR CANCER THERAPEUTICS (2011)
The VEGF pathway and the AKT/mTOR/p70S6K1 signalling pathway in human epithelial ovarian cancer
X. B. Trinh et al.
BRITISH JOURNAL OF CANCER (2009)
Prognostic significance of intratumoral and peritumoral lymphatic density and blood vessel density in invasive breast carcinomas
Yasser M. El-Gohary et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2008)
Prognostic value of Ki67 expression after short-term presurgical endocrine therapy for primary breast cancer
Mitch Dowsett et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
Antiangiogenic and antitumor effects of bevacizumab in patients with inflammatory and locally advanced breast cancer
SB Wedam et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Angiogenesis of breast cancer
BP Schneider et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Normalization of tumor vasculature: An emerging concept in antiangiogenic therapy
RK Jain
SCIENCE (2005)
Vascular normalization by vascular endothelial growth factor receptor 2 blockade induces a pressure gradient across the vasculature and improves drug penetration in tumors
RT Tong et al.
CANCER RESEARCH (2004)
Neoadjuvant chemotherapy in breast cancer: Significantly enhanced response with docetaxel
IC Smith et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
New guidelines to evaluate the response to treatment in solid tumors
F Duffaud et al.
BULLETIN DU CANCER (2000)
New guidelines to evaluate the response to treatment in solid Tumors
P Therasse et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
分享论文
